- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.40 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x FAD: FLAVIN-ADENINE DINUCLEOTIDE(Non-covalent)
- 4 x K: POTASSIUM ION(Non-covalent)
K.2: 5 residues within 4Å:- Chain A: Q.338, D.345, A.500, Q.501, F.503
5 PLIP interactions:3 interactions with chain A, 2 Ligand-Water interactions- Metal complexes: A:D.345, A:Q.501, A:F.503, H2O.2, H2O.14
K.7: 5 residues within 4Å:- Chain B: Q.338, D.345, A.500, Q.501, F.503
5 PLIP interactions:3 interactions with chain B, 2 Ligand-Water interactions- Metal complexes: B:D.345, B:Q.501, B:F.503, H2O.23, H2O.34
K.12: 5 residues within 4Å:- Chain C: Q.338, D.345, A.500, Q.501, F.503
5 PLIP interactions:3 interactions with chain C, 2 Ligand-Water interactions- Metal complexes: C:D.345, C:Q.501, C:F.503, H2O.43, H2O.54
K.17: 5 residues within 4Å:- Chain D: Q.338, D.345, A.500, Q.501, F.503
5 PLIP interactions:3 interactions with chain D, 2 Ligand-Water interactions- Metal complexes: D:D.345, D:Q.501, D:F.503, H2O.63, H2O.74
- 4 x MG: MAGNESIUM ION(Non-covalent)
MG.3: 5 residues within 4Å:- Chain A: D.545, N.572, E.574, G.576
- Ligands: TZD.5
3 PLIP interactions:2 interactions with chain A, 1 Ligand-Water interactions- Metal complexes: A:D.545, A:E.574, H2O.4
MG.8: 5 residues within 4Å:- Chain B: D.545, N.572, E.574, G.576
- Ligands: TZD.10
3 PLIP interactions:2 interactions with chain B, 1 Ligand-Water interactions- Metal complexes: B:D.545, B:E.574, H2O.24
MG.13: 5 residues within 4Å:- Chain C: D.545, N.572, E.574, G.576
- Ligands: TZD.15
3 PLIP interactions:2 interactions with chain C, 1 Ligand-Water interactions- Metal complexes: C:D.545, C:E.574, H2O.45
MG.18: 5 residues within 4Å:- Chain D: D.545, N.572, E.574, G.576
- Ligands: TZD.20
3 PLIP interactions:2 interactions with chain D, 1 Ligand-Water interactions- Metal complexes: D:D.545, D:E.574, H2O.65
- 4 x 6R4: methyl 2-[(4-methyl-5-oxidanylidene-3-propoxy-1,2,4-triazol-1-yl)carbonylsulfamoyl]benzoate(Non-covalent)
6R4.4: 15 residues within 4Å:- Chain A: M.349, D.374, R.375, W.581, A.652
- Chain D: G.111, A.112, V.186, P.187, A.190, A.195, F.196, Q.197, K.246
- Ligands: FAD.1
11 PLIP interactions:7 interactions with chain D, 4 interactions with chain A- Hydrophobic interactions: D:V.186, D:A.190, D:A.195, D:F.196
- Hydrogen bonds: D:K.246, D:K.246, A:R.375, A:R.375
- Salt bridges: D:K.246
- pi-Stacking: A:W.581
- pi-Cation interactions: A:R.375
6R4.9: 15 residues within 4Å:- Chain B: M.349, D.374, R.375, W.581, A.652
- Chain C: G.111, A.112, V.186, P.187, A.190, A.195, F.196, Q.197, K.246
- Ligands: FAD.6
11 PLIP interactions:7 interactions with chain C, 4 interactions with chain B- Hydrophobic interactions: C:V.186, C:A.190, C:A.195, C:F.196
- Hydrogen bonds: C:K.246, C:K.246, B:R.375, B:R.375
- Salt bridges: C:K.246
- pi-Stacking: B:W.581
- pi-Cation interactions: B:R.375
6R4.14: 15 residues within 4Å:- Chain B: G.111, A.112, V.186, P.187, A.190, A.195, F.196, Q.197, K.246
- Chain C: M.349, D.374, R.375, W.581, A.652
- Ligands: FAD.11
11 PLIP interactions:7 interactions with chain B, 4 interactions with chain C- Hydrophobic interactions: B:V.186, B:A.190, B:A.195, B:F.196
- Hydrogen bonds: B:K.246, B:K.246, C:R.375, C:R.375
- Salt bridges: B:K.246
- pi-Stacking: C:W.581
- pi-Cation interactions: C:R.375
6R4.19: 15 residues within 4Å:- Chain A: G.111, A.112, V.186, P.187, A.190, A.195, F.196, Q.197, K.246
- Chain D: M.349, D.374, R.375, W.581, A.652
- Ligands: FAD.16
11 PLIP interactions:7 interactions with chain A, 4 interactions with chain D- Hydrophobic interactions: A:V.186, A:A.190, A:A.195, A:F.196
- Hydrogen bonds: A:K.246, A:K.246, D:R.375, D:R.375
- Salt bridges: A:K.246
- pi-Stacking: D:W.581
- pi-Cation interactions: D:R.375
- 4 x TZD: 2-{3-[(4-AMINO-2-METHYLPYRIMIDIN-5-YL)METHYL]-4-METHYL-2-OXO-2,3-DIHYDRO-1,3-THIAZOL-5-YL}ETHYL TRIHYDROGEN DIPHOSPHATE(Non-covalent)
TZD.5: 26 residues within 4Å:- Chain A: V.492, G.493, Q.494, H.495, G.518, M.520, G.544, D.545, A.546, S.547, M.550, N.572, E.574, Q.575, G.576, M.577, V.578
- Chain D: Y.108, A.109, G.110, E.134, T.157, P.160, N.164, Q.197
- Ligands: MG.3
18 PLIP interactions:15 interactions with chain A, 3 interactions with chain D- Hydrophobic interactions: A:Q.575, D:Y.108, D:P.160
- Hydrogen bonds: A:V.492, A:Q.494, A:H.495, A:G.518, A:M.520, A:D.545, A:A.546, A:S.547, A:N.572, A:N.572, A:G.576, A:M.577, D:Q.197
- Salt bridges: A:H.495, A:H.495
TZD.10: 26 residues within 4Å:- Chain B: V.492, G.493, Q.494, H.495, G.518, M.520, G.544, D.545, A.546, S.547, M.550, N.572, E.574, Q.575, G.576, M.577, V.578
- Chain C: Y.108, A.109, G.110, E.134, T.157, P.160, N.164, Q.197
- Ligands: MG.8
18 PLIP interactions:3 interactions with chain C, 15 interactions with chain B- Hydrophobic interactions: C:Y.108, C:P.160, B:Q.575
- Hydrogen bonds: C:Q.197, B:V.492, B:Q.494, B:H.495, B:G.518, B:M.520, B:D.545, B:A.546, B:S.547, B:N.572, B:N.572, B:G.576, B:M.577
- Salt bridges: B:H.495, B:H.495
TZD.15: 26 residues within 4Å:- Chain B: Y.108, A.109, G.110, E.134, T.157, P.160, N.164, Q.197
- Chain C: V.492, G.493, Q.494, H.495, G.518, M.520, G.544, D.545, A.546, S.547, M.550, N.572, E.574, Q.575, G.576, M.577, V.578
- Ligands: MG.13
19 PLIP interactions:15 interactions with chain C, 4 interactions with chain B- Hydrophobic interactions: C:Q.575, B:Y.108, B:P.160
- Hydrogen bonds: C:V.492, C:Q.494, C:H.495, C:G.518, C:M.520, C:D.545, C:A.546, C:S.547, C:N.572, C:N.572, C:G.576, C:M.577, B:Q.197
- Salt bridges: C:H.495, C:H.495
- Water bridges: B:E.134
TZD.20: 26 residues within 4Å:- Chain A: Y.108, A.109, G.110, E.134, T.157, P.160, N.164, Q.197
- Chain D: V.492, G.493, Q.494, H.495, G.518, M.520, G.544, D.545, A.546, S.547, M.550, N.572, E.574, Q.575, G.576, M.577, V.578
- Ligands: MG.18
19 PLIP interactions:15 interactions with chain D, 4 interactions with chain A- Hydrophobic interactions: D:Q.575, A:Y.108, A:P.160
- Hydrogen bonds: D:V.492, D:Q.494, D:H.495, D:G.518, D:M.520, D:D.545, D:A.546, D:S.547, D:N.572, D:N.572, D:G.576, D:M.577, A:Q.197
- Salt bridges: D:H.495, D:H.495
- Water bridges: A:E.134
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Garcia, M.D. et al., Commercial AHAS-inhibiting herbicides are promising drug leads for the treatment of human fungal pathogenic infections. Proc. Natl. Acad. Sci. U.S.A. (2018)
- Release Date
- 2018-09-26
- Peptides
- Acetolactate synthase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.40 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x FAD: FLAVIN-ADENINE DINUCLEOTIDE(Non-covalent)
- 4 x K: POTASSIUM ION(Non-covalent)
- 4 x MG: MAGNESIUM ION(Non-covalent)
- 4 x 6R4: methyl 2-[(4-methyl-5-oxidanylidene-3-propoxy-1,2,4-triazol-1-yl)carbonylsulfamoyl]benzoate(Non-covalent)
- 4 x TZD: 2-{3-[(4-AMINO-2-METHYLPYRIMIDIN-5-YL)METHYL]-4-METHYL-2-OXO-2,3-DIHYDRO-1,3-THIAZOL-5-YL}ETHYL TRIHYDROGEN DIPHOSPHATE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Garcia, M.D. et al., Commercial AHAS-inhibiting herbicides are promising drug leads for the treatment of human fungal pathogenic infections. Proc. Natl. Acad. Sci. U.S.A. (2018)
- Release Date
- 2018-09-26
- Peptides
- Acetolactate synthase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A